Candriam Equities L Biotech.C-H EUR Acc/ LU1120766206 /
| NAV9/5/2024 | Chg.-2.3400 | Type of yield | Investment Focus | Investment company |
|---|---|---|---|---|
| 213.5900EUR | -1.08% | reinvestment | Equity Worldwide | Candriam ▶ |
Monthly performance
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2015 | - | 4.50 | 1.83 | -5.03 | 10.78 | 0.59 | 4.26 | -10.61 | -11.54 | 7.84 | 3.34 | 0.40 | +4.26% |
| 2016 | -23.30 | -4.50 | 3.68 | 3.70 | 5.38 | -8.64 | 12.35 | -2.51 | 3.83 | -12.88 | 9.14 | -3.00 | -20.47% |
| 2017 | 5.33 | 6.69 | -0.05 | 0.89 | -3.15 | 9.22 | 2.21 | 6.71 | 0.69 | -6.82 | -0.16 | 1.27 | +24.05% |
| 2018 | 6.44 | -4.86 | -2.41 | -3.43 | 4.27 | 0.55 | 4.17 | 3.82 | -2.27 | -14.27 | 3.77 | -8.62 | -14.03% |
| 2019 | 12.76 | 3.32 | -0.89 | -5.21 | -4.74 | 9.15 | -2.47 | -2.55 | -4.76 | 10.91 | 11.78 | 2.49 | +30.88% |
| 2020 | -5.47 | -1.64 | -5.49 | 12.16 | 9.41 | 1.19 | -3.05 | 0.74 | 0.56 | -2.77 | 9.29 | 2.82 | +17.10% |
| 2021 | 1.73 | -2.65 | -4.44 | 2.62 | -2.35 | 6.25 | -1.54 | 3.80 | -4.36 | 0.09 | -4.46 | 2.24 | -3.71% |
| 2022 | -10.71 | -1.69 | 5.75 | -7.90 | -4.17 | 3.06 | 4.53 | 1.25 | -2.38 | 6.14 | 5.87 | -3.28 | -5.21% |
| 2023 | 2.66 | -5.87 | 0.05 | 2.69 | -1.17 | 1.20 | -0.77 | -0.42 | -4.65 | -6.26 | 5.89 | 13.33 | +5.25% |
| 2024 | 1.37 | 1.17 | -0.16 | -6.40 | 3.63 | 5.48 | 6.17 | 1.57 | -3.19 | - | - | - | - |
Calculated values
| YTD | 6 Months | 1 Year | 3 Years | 5 Years | |
|---|---|---|---|---|---|
| Volatility | 16.40% | 16.32% | 17.35% | 20.12% | 22.58% |
| Sharpe ratio | 0.65 | 0.59 | 0.82 | -0.15 | 0.22 |
| Best month | +13.33% | +6.17% | +13.33% | +13.33% | +13.33% |
| Worst month | -6.40% | -6.40% | -6.40% | -10.71% | -10.71% |
| Maximum loss | -11.27% | -9.27% | -11.83% | -29.34% | -32.47% |
| Outperformance | +0.20% | - | +1.23% | -7.79% | -6.03% |
All quotes in EUR
Share classes
| Name | Type of yield | Repurchase p. | 1 Year | 3 Years | |
|---|---|---|---|---|---|
| Candriam Equities L Biotech.I-H ... | reinvestment | 2,232.7200 | +18.09% | +1.60% | |
| Candriam Equities L Biotech.I EU... | reinvestment | 2,360.5801 | +16.49% | +16.79% | |
| Candriam Equities L Biotech.I GB... | reinvestment | 3,575.9500 | +14.99% | +13.24% | |
| Candriam Equities L Biotech.V2 U... | reinvestment | 2,013.0300 | +21.43% | +12.73% | |
| Candriam Equities L Biotech.C EU... | reinvestment | 234.0100 | +15.98% | +16.50% | |
| Candriam Equities L Biotech.R GB... | reinvestment | 376.1700 | +15.57% | +17.23% | |
| Candriam Equities L Biotech.R EU... | reinvestment | 346.2200 | +17.08% | +19.63% | |
| Candriam Equities L Biotech.R-H ... | reinvestment | 216.5400 | +15.73% | -0.30% | |
| Candriam Equities L Biotechnolog... | reinvestment | 161.5000 | - | - | |
| Candriam Equities L Biotech.N US... | reinvestment | 651.6500 | +19.62% | +7.80% | |
| Candriam Equities L Biotech.I US... | reinvestment | 6,133.8701 | +20.49% | +9.16% | |
| Candriam Equities L Biotechnolog... | reinvestment | 2,242.9500 | +20.64% | +9.55% | |
| Candriam Equities L Biotech.C-H ... | reinvestment | 213.5900 | +17.71% | +1.53% | |
| Candriam Equities L Biotech.R US... | reinvestment | 291.5600 | +21.13% | +11.88% | |
| Candriam Equities L Biotech.R-H ... | reinvestment | 223.2700 | +18.70% | +4.04% | |
| Candriam Equities L Biotechnolo... | reinvestment | 915.7000 | +20.06% | +9.13% | |
| Candriam Equities L Biotechnolog... | paying dividend | 836.2200 | +20.03% | +9.03% |
Performance
| YTD | +9.37% | ||
|---|---|---|---|
| 6 Months | +6.39% | ||
| 1 Year | +17.71% | ||
| 3 Years | +1.53% | ||
| 5 Years | +49.50% | ||
| 10 Years | - | ||
| Since start | +42.39% | ||
| Year | |||
| 2023 | +5.25% | ||
| 2022 | -5.21% | ||
| 2021 | -3.71% | ||
| 2020 | +17.10% | ||
| 2019 | +30.88% | ||
| 2018 | -14.03% | ||
| 2017 | +24.05% | ||
| 2016 | -20.47% | ||
| 2015 | +4.26% | ||
